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Although encouraging initial results have been 
demonstrated after directional atherectomy, the 
mechanisms and predictors of late lumen loss 
and restenesis after this precedure have not 
been evaluated. To examine these issues, clinical 
and angiographic followup were obtained in 262 
(96%) and 212 (77%) of 274 patients undergoing 
successful directional coronary atherectomy. 
Symptom recurrence developed in 67 (33%) 
patients and angrographic restenosis was found 
in 93 (44%). Restenosis was highest in restenotic 
lesions in saphenous vein grafts (76% [95% confi- 
dence interval (Cl): 56 to 100X]) and lowest in 
new-nset lesions in the left anterior descending 
(27% [95% Cl: 15 to 39%]) and circumflex (14% 
[95% Cl: 0 to 43%]) coronary arteries. Residual 
lumen diameter immediately after atherectomy 
was smaller in re-stenotic lesions (p q 0.002) and 
in lesions 210 mm in length (p q 0.02). Late 
lumen loss was associated with the minimal 
lumen diameter immediately after atherectomy 
(p <O.OOl), saphenous vein graft lesion location 
(p = 0.006), and male gender (p = 0.02). Restenot- 
ic ]esions (p cO.OOl), lesions 210 mm in length 
(p = 0.016), saphenous vein graft lesion location 
(p = 0.025) and male gender (p = 0.045) were 
independent predictors for restenosis. lt is con- 
cluded that restenosis after directional athe- 
tomy is related both to factors resulting in a sub 
optimal initial result and to factors contributing 
to excessive late lumen loss. These resutts may 
have implications for lesion selection in patients 
undergoing directional coronary atherectomy. 
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A variety of investigational angioplasty devices have been used in an attempt to reduce the inci- dence of restenosis after coronary angioplasty,r” 
although with somewhat limited success.2’4,5 Angio- 
graphic restenosis has been reported in 30 to 50% of 
patients after directional coronary atherectomy,6,7 similar 
to restenosis rates for balloon angioplast$ despite an 
improved immediate angiographic result with this proce- 
dure.9,10 A recent clinical study suggests that the larger 
lumen dimensions initially obtained with investigational 
angioplasty devices may be partially offset by greater 
degrees of intimal hyperplasia and recoil during the fol- 
low-up period.” To date, however, the precise clinical, 
angiographic and procedural factors associated with late 
lumen loss and restenosis after directional atherectomy 
remain largely undetined. To identify these factors, we 
reviewed the late clinical outcome of 262 patients under- 
going directional atherectomy at 5 clinical centers. 
Cineangiograms, obtained in 212 patients (77%) before, 
immediately after and late (0.5 to 15.8 months) after 
directional atherectomy, were analyzed using qualitative 
morphologic and quantitative angiographic methods. 
The determinants of late lumen loss and restenosis were 
then examined. 
METHODS 
Patient population: From June 1988 to May 1990, 
directional coronary atherectomy was performed in 318 
procedures (305 patients) at 5 clinical sites (Appendix). 
Proximal lesions and lesions with marked eccentricity or 
irregularity within coronary arteries or saphenous vein 
grafts of sufficient caliber to allow passage of the ather- 
ectomy device (22.5 mm) were considered suitable for 
directional atherectomy. Procedural success, defined as 
~50% residual diameter stenosis, tissue retrieval, and the 
absence of in-hospital ischemic complications, was ob- 
tained in 274 procedures (86%).12,13 Before atherectomy, 
all patients gave written informed consent, approved by 
the respective institutional review boards, 
After hospital discharge, 262 patients (96%) were 
followed for recurrent symptoms of angina or other clin- 
ical evidence of myocardial ischemia; the remaining 12 
patients were lost to follow-up. Exercise treadmill test- 
ing was obtained 4 to 6 months after atherectomy in 174 
patients (66%), but was not performed in 88 patients 
(34%) because of unstable angina, physician or patient 
refusal. Coronary arteriography was performed in 212 
patients (77%) 6.1 f 2.5 months (range 0.2 to 15.8) after 
directional atherectomy. 
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TABLE I Late Clinical Follow-Up After Directional Atherectomy ( 
No Angiographic Angiographic No Follow-Up 
Restenosis Restenosis Arteriography 
(n = 119) (%I (n = 93) (%I (n = 50) (%I 
No Symptoms of Recurrent lschemia 
Negative ETT 67 (56) 10 (11) 2 (4) 
Positive ETT 11 (9) 12 (13) 30 (60) 
No ETT performed 24 (20) 5 (5) 14 (28) 
Symptoms of Recurrent lschemia 
Negative ETT 3 (3) 7 (7) 2 (4) 
Positive ETT 6 (5) 23 (25) 1 (2) 
No ETT performed 8 (7) 36 (39) 1 (2) 
ETT = exercise treadmill test. 
Clinical and procedural variablea: Case report forms 
were reviewed for selected clinical features including 
age, gender, angina status, and the presence of diabetes, 
unstable angina or a prior history of restenosis. Atherec- 
tomy device size, peak balloon inflation pressure, num- 
ber of specimens excised, and number of atherectomy 
passes were also recorded. A positive exercise treadmill 
test response was defined as clinical (typical chest pain) 
or electrocardiographic (N.1 mV ST-segment depres- 
sion) evidence of ischemia during exercise stress testing. 
QuMative mgiogqMi mdysic Cineangiograms, 
obtained before and after directional atherectomy were 
reviewed at the University of Michigan core angio- 
graphic laboratory. Lesions were visualized in multiple 
projections and scored according to the presence or ab- 
sence of 9 previously detied angiographic criteria.12J3 
These morphologic criteria included: diffuse proximal 
disease, lesion eccentricity, bend 245”, proximal vessel 
tortuosity, lesion irregularity, lesion calctication, bifur- 
cation lesion, thrombus-containing lesion, and lesion 210 
mm in length The device:artery ratio was measured by 
calipers and delined as the ratio of the atherectomy 
device to the normal adjacent coronary artery for the 
largest device that crossed the stenosis. The presence of 
multivessel coronary disease was recorded after review 
of the cineangiograms by the principal investigators. In 
the 212 patients with angiographic follow-up, restenosis 
was delined as a residual diameter stenosis 250% at time 
of follow-up. 
Quantitative an&ographic analysis: Quantitative 
coronary analysis was performed in 193 lesions before, 
immediately after and late after directional atherectomy. 
In 19 lesions not suitable for quantitative analysis 
because of absence of an image calibration factor or 
poor angiographic quality in 1 or more studies, percent 
stenosis was calculated using digital calipers. End-dia- 
stolic cineframes, selected whenever possible from or- 
thogonal projections, were matched before, immediate- 
ly after and late after directional atherectow. The select- 
ed cineframes were digitized using a &e-video converter, 
and a computer-assisted edge-detection algorithm was 
applied to the arterial and catheter contours.14 Using the 
diagnostic or guiding catheter as the calibration standard, 
reference and minimal lumen diameters were deter- 
mined. From the orthogonal projections, average refer- 
ence and minimal lesion lumen diameters before, imme- 
TABLE II Quantitative Coronary Dimensions After Directional 
Atherectomy 
No 
Restenosis Restenosis Overall 
(n = 99) (n = 94) (n = 193) 









Late lumen loss* 




Lesion length (mm)t 
*p CO.001; fp <0.05. 
3.5 k 0.6 3.4 t 0.7 
3.6 2 0.6 3.4 k 0.7 
3.5 2 0.7 3.5 + 0.7 
1.2 3 0.5 1.1 * 0.5 
3.0 2 0.8 2.8 2 0.9 
2.7 r 1.0 1.1 !Y 0.6 
1.8 2 0.8 1.7 k 0.9 
0.3 t 1.1 1.7 + 1.0 
67 IT 13 69 f 14 
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5.2 L 3.8 7.4 + 5.3 
3.5 -c 0.7 
3.5 k 0.7 
3.5 k 0.7 
1.1 t- 0.5 
2.9 -c 0.9 
1.9 f 1.2 
1.8 L 0.9 
1.0 2 1.3 
68 + 13 
16” 21 
45 2 29 
6.2 2 4.6 
diately after and late after directional atberectomy were 
calculated. Acute gain was defmed as the difference in 
minimal lumen diameter (in millimeters) before and 
immediately after directional atherectomy. Late lumen 
loss was defmed as the loss in postprocedural minimal 
lumen diameter (in millimeters) during tlk follow-up 
period compared with the minimal lumen diameter 
immediately after the procedure.‘l 
Statistical analysis: Continuous variables are pre- 
sented as mean + 1 SD; categorical variables are pre- 
sented as frequencies with 95% confidence intervals 
(CI), where appropriate. Differences in continuous vati- 
ables were analyzed using nonparametric analysis 
(Mann-Whitney U test), whereas tierences in propor- 
tions between clinical and angiographic characterisiics 
were assessed using &i-square test or the Fisher’s exact 
test when >20% of the cells had an expected value ,<5. 
The odds ratio was obtained by: 
Probability of restenosis, variable present 
Probability of no restenosis, variable present 
Probability of restenosis, variable absent 
Probability of no restenosis, variable absent 
Multivariate linear and logistic regression analyses 
were performed using SYSTAT software (System for 
Statistics, Evanston, Illinois) on clinical and angio- 
graphic variables with a p co.15 in the univariate anal- 
ysis. Features with ~20 observations were not included. 
A p value co.05 was considered statistically signkant. 
RESULTS 
Symptom recumnca after diractional athawec- 
tomy: During the follow-up period, 175 patients (67%) 
remained asymptomatic (Table I). Angiographic follow- 
up was available in 129 asymptomatic patients (74%); 
27 of them (21%) developed restenosis. Of the 46 
asymptomatic patients who did not undergo arteriogra- 
phy, 30 (65%) had exercise treadmill tests suggestivle of 
recurrent ischemia. Angiographic follow-up was also 
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TABLE III Correlates of Residual Lumen Diameter, Late Lumen Loss and Restenosis After 
Directional Atherectomy 
Residual Lumen Restenosis 




Univariate p Multivariate p Univariate p Multivariate p p P 
Clinical factors 
Male gender >0.15 0.020 0.020 0.025 0.045 
(0.530) (0.466) 
History of 0.002 0.001 >0.15 - 0.003 <O.OOl 
restenosis (-0.400) C-0.468) 
Angiographic factors 
SVG location >0.15 0.038 0.008 0.058 0.025 
(0.549) (0.627) 
Lesion length 0.020 0.019 >0.15 - 0.010 0.018 
rlOmm (-0.493) C-0.425) 
Procedural factors 
Residual lumen - - <O.OOl <O.OOl 0.106 >0.15 
diameter after CO.6571 (0.594) 
atherectomy 
R = 0.328 R = 0.503 p <O.OOl 
SEE = 0.766 SEE = 0.988 
p <O.OOl p <O.OOl 
SVG = saphenous vein graft; - = not entered into the univariate or multivariate analysis. 
1 
available in 83 of 87 patients (95%) with recurrent angi- 
na after atherectomy; restenosis was found in 66 (80%). 
Recurrent angina in the 17 patients (20%) without an- 
giographic restenosis was attributed to concomitant mul- 
tivessel coronary artery disease or progression of other 
lesions not involved in the initial atherectomy procedure. 
Overall restenosis after directional atherectomy: 
Angiographic restenosis developed in 93 lesions (44%) 
after directional atherectoq. Restenosis rates were high- 
er in restenotic lesions within saphenous vein grafts (11 
of 14 [78%: 95% CI: 56 to NO%]) than in restenotic 
lesions within the left anterior descending (29 of 47 
[62%: 95% CI: 48 to 76%]), left circumflex (3 of 7 
[43%: 95% CI: 6 to 80%]) and right coronary (10 of 24 
[42%: 95% CI: 20 to 64%]) arteries. Restenosis rates 
were lower in new lesions within the left anterior de- 
scending (15 of 55 [27%: 95% CI: 15 to 39%]) and cir- 
cumllex coronary (1 of 7 [14%: 95% CI: 0 to 43%]) 
arteries than in new lesions within the right coronary 
artery (10 of 23 [43%: 95% CI: 23 to 63%]) and saphe- 
nous vein grafts (4 of 10 [40%: 95% CI: 10 to 70%]). 
Factors affecting acute gain after directional 
atherectomy: In the subset of 193 patients in whom 
serial angiographic studies were available, minimal 
lumen diameters were significantly smaller in restenotic 
lesions (2.6 + 0.7 vs 3.0 + 0.8 for new lesions; 
p = 0.002) and in lesions 210 mm in length (2.4 k 0.7 
vs 2.9 f 0.8 mm for lesions ~10 mm in length; 
p = 0.02). Acute gain was also less in restenotic lesions 






Acute gain tended to be less in lesions 210 mm in length 
(1.5 + 0.8 vs 1.8 f 0.8 mm for lesions ~10 mm in 
length), but this difference was not statistically signifi- 
cant (p = 0.13). Residual lumen diameters and acute gain 
were not otherwise affected by gender, vessel location, 
or the presence of unfavorable morphologic features. 
Residual lumen diameters after atherectomy tended to be 
smaller in lesions with late restenosis, although this dif- 
ference was not significant (p = 0.11). Differences in 
acute gain between the 2 groups did not achieve statis- 
0 tical significance (Table II). Restenosis developed in 19 
0 1 2 3 4 5 of 47 lesions (40%) with a residual minimal lumen 
Minimal Diameter (mm) diameter 23.5 mm immediately after atherectomy com- 
pared with 74 of 165 lesions (45%) with a residual min- 
FlGUREi.Cumulativefrequency distributioncurveofquaatk imal lumen diameter ~3.5 mm. 
tative coronary dimensions before (Pw-Ath), immediately 3 
ter (Post-Ath) and late (FwAth) after directional atherecto- 
Predictors of late lumen loss after directional 
my. Early improvements in luminal dimensioas (acute gain) atherectomy: During the follow-up period, late lumen 
are denoted by ri#tsvard a~y)ws and late lumen loss is loss averaged 1.0 + 1.3 mm (Table II), resulting in a net 
denotedbytheleftwanfanww. lumen gain of 0.8 f 1.1 mm after directional atherec- 
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tomy (Figure 1). In 117 lesions (55%), lumen loss dur- 
ing the follow-up period exceeded 0.72 mm. In 29 le- 
sions (18%), an improvement of 0.6 f 0.5 mm in mini- 
mal lumen diameter developed during the follow-up 
period. 
sure, or Iinal percent diameter stenosis, were not signili- 
cantly related to restenosis (Table IV). 
DISCUSSION 
Using multivariate linear regression analysis, late lu- 
men loss was independently associated with the mini- 
mal lumen diameter immediately after directional 
atherectomy (p <O.OOl), saphenous vein graft lesion 
location (p = 0.008) and male gender (p = 0.02) (Table 
III). Moreover, late lumen loss was independently asso- 
ciated with the residual percent diameter stenosis imme- 
diately after directional atherectomy (R = 0.420; 
SEE = 1.056; p <O.OOl) (Figure 2). Late lumen loss was 
not related to such procedural factors as the 
deviceartery ratio, number of specimens retrieved, or 
the balloon pressure during directional atherectomy. 
The clinical and angiographic follow-up of 262 pa- 
tients undergoing directional coronary atherectomy at 5 
clinical centers is reported. During the 4- to 6-month ml- 
low-up period, angiographic restenosis developed in 93 
of 212 lesions (44%) with late angiography. Several clin- 
ical and angiographic factors affecting both acute g,ain 
and late lumen loss after directional atherectomy were 
associated with restenosis, suggesting that, similar to 
&- 
Risk factors for restenosis after directiond 
atherectomy: The clinical, angiographic and procedu- 
ral characteristics by restenosis status are presented in 
Table IV Male gender, restenotic lesions, diffuse proxi- 
mal disease, saphenous vein graft lesion location and 
lesions Xl0 mm in length imparted a twofold or greater 
risk of restenosis after directional atherectomy. Angio- 
graphic restenosis developed in 60 of 143 lesions (42%) 
with 25 specimens retrieved and in 23 of 57 lesions 
(40%) with ~5 specimens retrieved. Logistic regression 
analysis also revealed that restenotic lesions (p <O.OOl), 
lesions 210 mm (p = O.OlS), saphenous vein graft lesion 
location (p = 0.025) and male gender (p = 0.045) were 
risk factors for angiographic restenosis (Table III). Other 
procedural factors, such as the atherectomy device size, 
number of specimens retrieved, balloon intlation pres- 
6- I . 
. I R = 0.420 
-. I SEE = 1.056 
4. I p < 0.001 
Late Lumen 
Loss (mm) 
-0.5 0.0 0.5 
Post-DCA Diameter Stenosis (%) 
FlGURE 2. Inverse relation between minimal lumen diameter 
immediately after directional atherectomy (Post-DCA) and 
late lumen loss. 
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coronary angioplasty, the mechanism of restenosis after 
directional atherectomy is multifactorial. 
Acute gain and late lumen loss after directiow 
al atherectomy: Nonrandomized series suggest that 
investigational devices may yield more favorable initial 
angiographic results than those obtained after balloon 
angioplasty,9,10 although the relation of these early lind- 
ings to late angiographic outcome has not been studied 
until recently. Using 3 investigational angioplasty 
devices, Kuntz et al” showed that new devices allow 
large initial gains in lumen diameter (2.6, 2.2 and 2.0 
mm for intracoronary stenting, directional atherectomy 
and laser balloon angioplasty, respectively). However, 
late lumen loss averaged 1.0 mm with each of the 
devices during the follow-up period, a lumen loss much 
greater than the 0.4 to 0.5 mm loss historically noted 
after balloon angioplasty. 15.16 Given similar degrees of 
late lumen loss with each device, variable restenosis 
rates were attributed to different degrees of acute gain 
initially achieved with each: the lowest rates were noted 
with intracoronary stents (19%), intermediate rates with 
directional atherectomy (31%), and highest rates with 
laser balloon angioplasty (50%). The authors concluded 
that the initial gains in coronary dimensions achieved 
with new angioplasty devices were partially negated by 
greater degrees of late lumen loss resulting from intimal 
hyperplasia and vascular recoil. Nevertheless, because 
the initial gains were generally of greater magnitude 
than late lumen loss, the ultimate restenosis rate was 
determined by the initial gain achieved immediately 
after the intervention. l l 
In the present report, an acute gain of 1.8 k 0.9 mm 
and residual lumen diameter of 2.9 + 0.9 mm were ob- 
tained immediately after directional atherectomy. Acute 
gain and residual lumen diameters were smaller in 
restenotic lesions and in lesions 210 in length, possibly 
accounting for the greater propensity for restenosis noted 
in these lesion subsets. The residual lumen diameter 
immediately after atherectomy tended to inversely relate 
to restenosis (p = O.ll), i.e., larger residual diameters had 
lower restenosis rates. Differences in lesion selection 
may account for the larger acute gain (2.2 mm) and 
lower restenosis rates (31%) in the series by Kuntz et 
al,” although reference segment diameters, residual 
lumen diameters and residual percent diameter stenoses 
were similar in the 2 reports, suggesting an equally ag- 
gressive approach to atheroma resection. Dissimilar an- 
giographic methods (digital calipers vs an automated 
edge-detection algorithm in the present series) may also 
have contributed to the differences in acute gain in the 
2 studies. 
Varying degrees of intimal hyperplasia and elastic 
recoil occur in most patients after investigational device 
use, culminating in clinical restenosis in some patients. 
In the present series, late lumen loss averaged 1.0 + 1.3 
mm after directional atherectomy, which is more than the 
0.4 to 0.5 mm lumen loss reported after balloon an- 
gioplasty.15J6 Our data suggest that late lumen loss is 
not constant after investigational device use, but varies 
in association with certain clinical, angiographic and 
procedural factors. Late lumen loss was greater with 
male gender and saphenous vein graft lesion location, 
features that have also been related to lumen loss after 
coronary angioplasty. 17,18 It was also directly related to 
the residual lumen diameter and inversely related to the 
percent diameter stenosis immediately after the proce- 
dure (Figure 2). These fmdings suggest that more ag- 
gressive atheroma resection may result in more pro- 
nounced intimal hyperplasia and elastic recoil during the 
follow-up period. Notably, the magnitude of late lumen 
loss (1.0 mm) was less than the magnitude of acute 
lumen gain (1.8 mm), resulting in a net improvement of 
0.8 mm in minimal lumen diameter late after the proce- 
dure. 
Incidence and correlates of restenosis after 
directional atherectomy: Depending on the deiinition 
used, restenosis rates of 30 to 50% have been reported 
after directional atherectomy.7,8J1 Restenosis, delined as 
a visually determined diameter stenosis 250% or >50% 
loss of the initial gain at the time of follow-up arteriog- 
raphy, developed in 37 of 74 lesions (50%) in 1 series.8 
Increased age, the presence of diabetes mellitus, and le- 
sions within saphenous vein grafts were associated with 
higher rates of restenosis, although differences in reste- 
nosis rates between restenotic and new lesions (54 vs 
46%) did not reach statistical significance. Subintimal 
tissue resection increased the restenotic rate for saphe- 
nous vein grafts, suggesting that the extent of intimal 
hyperplasia may be related to the depth of resection 
within saphenous vein grafts. In another series, resteno- 
sis, delined as caliper-determined diameter stenosis 
>60%, developed in 30% of 67 lesions 6 months after 
directional atherectomy.7 In the present series, an over- 
all restenosis rate of 43% is reported. It was highest in 
restenotic lesions within saphenous vein grafts (78%), 
while lowest in new lesions within the left anterior de- 
scending (27%) and left circumflex (14%) coronary 
arteries. 
Our data suggest that at least 2 factors contribute to 
restenosis after directional atherectomy: a suboptimal 
initial gain in lumen diameter immediately after ather- 
ectomy and excessive late lumen loss. Smaller residual 
lumen diameters were obtained immediately after direc- 
tional atherectomy in restenotic lesions and in lesions 
210 mm in length. More pronounced late lumen loss 
occurred in men and in lesions involving saphenous vein 
g&S. 
Study limitations: Pathologic specimens were not 
available for histologic review and the impact of subinti- 
mal resection on late lumen loss and restenosis was not 
assessed in this report. The clinical importance of resec- 
tion of normal vessel wall is unclear,7J9~20 and further 
study will be needed to determine the optimal depth of 
cut after directional atherectomy. Moreover, despite the 
identification of predictive factors associated with late 
lumen loss after directional atherectomy, the explanato- 
ry ability of these factors is modest (R = 0.503). Un- 
doubtedly, other unidentified factors may also be impor- 
tant correlates of restenosis after directional atherectomy. 
Finally, our fmdings do not lend insight into the mech- 
anisms of late lumen loss after directional atherectomy 
i.e., vascular recoil versus intimal hyperplasia. Discrim- 
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ination between these factors may be important in fur- 
ther moditication of the lesion-specitic use of in- 
vestigational devices. 
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